Addus HomeCare Co. (NASDAQ:ADUS – Get Free Report) EVP Cliff Donald Blessing sold 178 shares of the business’s stock in a transaction that occurred on Monday, April 21st. The stock was sold at an average price of $101.17, for a total value of $18,008.26. Following the transaction, the executive vice president now owns 10,401 shares in the company, valued at $1,052,269.17. The trade was a 1.68 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.
Addus HomeCare Price Performance
ADUS stock opened at $99.54 on Friday. Addus HomeCare Co. has a 12 month low of $88.96 and a 12 month high of $136.72. The firm has a market capitalization of $1.81 billion, a PE ratio of 22.78, a P/E/G ratio of 1.41 and a beta of 0.93. The company’s 50 day simple moving average is $98.20 and its 200-day simple moving average is $116.35.
Addus HomeCare (NASDAQ:ADUS – Get Free Report) last released its quarterly earnings results on Monday, February 24th. The company reported $1.26 earnings per share for the quarter, missing the consensus estimate of $1.35 by ($0.09). Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The company had revenue of $297.14 million for the quarter, compared to analysts’ expectations of $291.04 million. As a group, sell-side analysts anticipate that Addus HomeCare Co. will post 4.59 earnings per share for the current year.
Institutional Inflows and Outflows
Wall Street Analyst Weigh In
A number of research analysts recently weighed in on ADUS shares. Stephens reaffirmed an “overweight” rating and set a $142.00 price objective on shares of Addus HomeCare in a report on Wednesday, March 12th. Macquarie reaffirmed an “outperform” rating and set a $129.00 price target on shares of Addus HomeCare in a research note on Thursday, February 27th. StockNews.com cut shares of Addus HomeCare from a “buy” rating to a “hold” rating in a research note on Wednesday, February 26th. Oppenheimer upped their target price on shares of Addus HomeCare from $145.00 to $150.00 and gave the stock an “outperform” rating in a research report on Friday, January 24th. Finally, JMP Securities reiterated a “market outperform” rating and set a $150.00 price target on shares of Addus HomeCare in a research report on Tuesday. One research analyst has rated the stock with a hold rating, seven have assigned a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Buy” and a consensus target price of $139.00.
Read Our Latest Analysis on ADUS
Addus HomeCare Company Profile
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Featured Articles
- Five stocks we like better than Addus HomeCare
- Bank Stocks – Best Bank Stocks to Invest In
- 2 Strong Utilities Plays With Booming Earnings and Room to Grow
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Why Smart Investors Don’t Panic in Election Season
- How is Compound Interest Calculated?
- Now Is the Time to Buy ServiceNow—The Rebound Is Real
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.